FAKTOR-OPTIONSSCHEIN - EVOTEC Share Price

Certificat

DE000SQ6WE88

Delayed Deutsche Boerse AG 08:51:54 26/06/2024 BST
0.23 EUR +4.55% Intraday chart for FAKTOR-OPTIONSSCHEIN - EVOTEC
Current month-4.35%
1 month-15.38%
Date Price Change
26/06/24 0.23 +4.55%
25/06/24 0.22 +10.00%
24/06/24 0.2 +11.11%
21/06/24 0.18 -5.26%
20/06/24 0.19 +46.15%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 08:51 am

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying EVOTEC SE
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6WE8
ISINDE000SQ6WE88
Date issued 30/12/2022
Strike 14.98
Maturity Unlimited
Parity 1 : 1
Emission price 10.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 25.63
Lowest since issue 0.001

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.825 EUR
Average target price
20.79 EUR
Spread / Average Target
+135.58%
Consensus